Diane E Bennett
Affiliation: Centers for Disease Control and Prevention
- DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairsDiane E Bennett
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Emerg Infect Dis 8:1224-9. 2002..Foreign-born persons with TB may have been infected previously in high-prevalence countries; screening and preventive measures recommended by the Institute of Medicine could prevent TB reactivation in these cases...
- Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacyJeffrey A Johnson
Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
PLoS Med 5:e158. 2008..We used sensitive and simple tests to investigate evidence of transmitted drug resistance in antiretroviral drug-naïve persons and assess the clinical implications of minority drug-resistant variants...
- The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing worldDiane E Bennett
Global AIDS Program, National Centre for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Curr Opin Infect Dis 19:607-14. 2006..To describe surveillance measures to inform HIV drug-resistance prevention, as part of the public health approach to antiretroviral therapy in developing countries...
- Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000Diane E Bennett
Centers for Disease Control and Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, Georgia, USA
Am J Respir Crit Care Med 177:348-55. 2008..The goal for tuberculosis (TB) elimination in the United States is a TB disease incidence of less than 1 per million U.S. population by 2010, which requires that the latent TB infection (LTBI) prevalence be less than 1% and decreasing...
- The World Health Organization's global strategy for prevention and assessment of HIV drug resistanceDiane E Bennett
World Health Organization, Geneva, Switzerland
Antivir Ther 13:1-13. 2008..As of December 2007, 25 countries were planning or implementing the strategy; seven countries report results in this supplement...
- HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, VietnamHIEN TRAN NGUYEN
National Institute for Hygiene and Epidemiology, Hanoi, Vietnam
Antivir Ther 13:115-21. 2008..Estimating transmitted resistance in the infected population will enable the appropriateness of current antiretroviral drug regimens to be assessed and will inform plans for future HIVDR surveillance...
- Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004Visva Pillay
National Institute for Communicable Diseases, Johannesburg, South Africa
Antivir Ther 13:101-7. 2008....
- Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006Gugu Maphalala
Swaziland Ministry of Health and Social Welfare, National Reference Laboratory, Mbabane, Swaziland
Antivir Ther 13:95-100. 2008..We used the WHO's HIVDR threshold survey method to assess transmitted HIVDR in three antenatal clinic (ANC) sites along the corridor between the two most populous cities in Swaziland, where ART was introduced in 2003...
- Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, TanzaniaGeofrey R Somi
National AIDS Control Program, Dar es Salaam, Tanzania
Antivir Ther 13:77-82. 2008..We used the WHO HIVDR threshold survey method to assess transmitted HIVDR in Dar es Salaam where ART was introduced in 1995 and where approximately 11,000 people are currently on ART...
- Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversiesRobert W Shafer
Division of Infectious Diseases, Stanford University, Stanford, CA, USA
Antivir Ther 13:59-68. 2008..The process used to create a previously published list of drug resistance mutations for HIV-1 surveillance is reviewed and alternative approaches to this process are discussed...
- A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settingsMark Myatt
Division of Epidemiology, Institute of Ophthalmology, University College London, London EC1V 9EL, UK
Antivir Ther 13:37-48. 2008..The method is currently being used in several such settings...
- Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatmentDiane E Bennett
World Health Organization, Geneva, Switzerland
Antivir Ther 13:25-36. 2008..Transmitted drug resistant HIV strains will be seen first in cities or health districts where antiretroviral treatment (ART) has been widely available for years. WHO recommends countries begin surveillance in these areas...
- World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sitesMichael R Jordan
Tufts University School of Medicine, Boston, MA, USA
Antivir Ther 13:15-23. 2008..Performed regularly at representative sites, the data generated will inform evidence-based decision making regarding national and global ART regimen selection and minimize the emergence of HIVDR at a population level...
- Identifying the sources of tuberculosis in young children: a multistate investigationSumi J Sun
California Department of Health Services, Berkley, CA, USA
Emerg Infect Dis 8:1216-23. 2002..Potential differences between sources for patients <5 years of age and source patients that transmitted TB to adolescent and adult patients were identified...
- Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation modelAndrew N Phillips
HIV Epidemiology and Biostatistics Group, Department of Primary Care and Population Sciences, and Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, University College London, London, UK
Lancet 371:1443-51. 2008..Our aim was to study the potential consequences of such monitoring strategies, especially in terms of survival and resistance development...